Skip to main content

Duke Robotics Corp. Announces Closing of $9.2 Million Underwritten Public Offering and Uplisting to NASDAQ

Fort Lauderdale, FL, May 18, 2026 (GLOBE NEWSWIRE) — Duke Robotics Corp. (OTCQB: DUKR) (“Duke Robotics” or the “Company”), a leader in advanced robotics and drone-based solutions for civilian and defense markets, today announced it has closed on its previously announced underwritten public offering of 1,125,000 units (the “Units”) at a public offering price of $8.20 per Unit. Each Unit issued in the offering consists of one share of common stock, $0.0001 par value per share, and one warrant to purchase one share of common stock at an exercise price of $8.60 per share, and have a five year term. The shares of common stock and warrants comprising the Units are immediately separable and will be issued separately.  The shares of common stock and warrants began trading on the Nasdaq Capital Market on May 15, 2026, under the symbols...

Continue reading

Pyxis Tankers Announces Financial Results for the Three Months Ended March 31, 2026

Maroussi, Greece, May 18, 2026 – Pyxis Tankers Inc. (Nasdaq Cap Mkts: PXS), (the “Company”, “we”, “our”, “us” or “Pyxis Tankers”), an international diversified shipping company, today announced unaudited results for the three months ended March 31, 2026. For the three months ended March 31, 2026, our revenues, net, were $10.0 million, compared to $9.6 million for the same period in 2025. During the first quarter of 2026, our time charter equivalent (“TCE”) revenues were $9.9 million, an increase of $1.5 million, or 18.2%, over the comparable period in 2025. Our net income attributable to common shareholders and available to common shareholders for the first quarter ended March 31, 2026 was $2.4 million, compared to net income of $0.8 million for the same period in 2025. For the first quarter of 2026, net income per common share was $0.23...

Continue reading

Alpha Tau Announces First Quarter 2026 Financial Results and Provides Corporate Update

– Groundbreaking interim results from U.S. REGAIN trial in recurrent glioblastoma demonstrate 100% local disease control, 67% complete response rate, and favorable safety profile – – Completion of patient enrollment in the U.S. pivotal ReSTART trial in recurrent cutaneous squamous cell carcinoma, the Company’s first U.S. pivotal study – – Pooled data from two pancreatic cancer trials presented at Digestive Disease Week (DDW) 2026 demonstrated 100% local disease control and favorable safety, the first oral presentation of Alpha DaRT® pancreatic data at a premier international gastroenterology conference – – Abstracts accepted for presentation at the 2026 ASCO Annual Meeting and at the AHNS 12th International Conference on Head and Neck Cancer, reflecting growing scientific recognition across multiple...

Continue reading

Toll Brothers Announces Cameron Cove Now Open in Marietta, Georgia

New luxury home community offers flexible home designs and resort-inspired amenities in East Cobb MARIETTA, Ga., May 18, 2026 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced its newest community, Cameron Cove, is now open in Marietta, Georgia. Located in the desirable East Cobb area, this new community features flexible single-family home designs and planned resort-style amenities, all within minutes of premier shopping, dining, and entertainment options. The Sales Center and Carrington model home are now open at 1459 Belfair Dr in Marietta.Cameron Cove features a variety of home designs with 3 to 5 bedrooms and up to 3,361 square feet of living space. Options for basements, lofts, and additional bedrooms and bathrooms provide opportunities for personalization to...

Continue reading

Press Release: ATS: phase 2 data demonstrate the superiority of efdoralprin alfa over a standard-of-care augmentation therapy in achieving higher fAAT levels in AATD  

ATS: phase 2 data demonstrate the superiority of efdoralprin alfa over a standard-of-care augmentation therapy in achieving higher fAAT levels in AATDData from the head-to-head study show efdoralprin alfa normalized and maintained functional AAT levels in people living with alpha-1 antitrypsin deficiency Efdoralprin alfa is a recombinant protein distinct from plasma-derived therapy, which has been the standard-of-care for nearly 40 yearsParis, May 18, 2026. Data from the global ElevAATe phase 2 study (clinical study identifier: NCT05856331) demonstrated superiority of investigational efdoralprin alfa over standard-of-care therapy in achieving and maintaining normalized functional alpha-1 antitrypsin (fAAT) levels in adult patients with alpha-1 antitrypsin deficiency (AATD)-related emphysema. These results are being presented today...

Continue reading

project44 Delivers 34% New ARR Growth Fueled by AI Agent Momentum and Intelligent TMS Expansion

Shipper new ARR surges 52% year over year as enterprise logistics leaders deepen commitment to the Decision Intelligence Platform CHICAGO, May 18, 2026 (GLOBE NEWSWIRE) — project44, the Decision Intelligence Platform for the modern supply chain, today announced Q1 FY27 results: 34% year-over-year growth in new Annual Recurring Revenue (ARR), achieving 109% of plan. Multi-year deals drove 67% of new ARR, reflecting continued momentum in long-term customer commitments. Shipper New ARR grew 52% year over year, the fastest-growing segment in the business, and Shipper NRR improved approximately 300 basis points quarter over quarter, one of the largest single-quarter retention improvements in company history. Sustained NRR improvement and back-to-back plan overperformance are indicators that customers are embedding project44 deeper into...

Continue reading

Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend

CINCINNATI, May 18, 2026 (GLOBE NEWSWIRE) — Stockholders of Chemed Corporation (NYSE: CHE) today elected a slate of nine directors at the Company’s 2026 annual stockholders’ meeting.   Stockholders ratified the continuation of PricewaterhouseCoopers LLP as the Company’s independent accountants for 2026. The non-binding proposal on Chemed’s executive compensation was not approved. Dividend Declared Following the stockholders’ meeting, Chemed’s Board of Directors declared a quarterly cash dividend of 60 cents per share on the Company’s capital stock, payable on June 16, 2026, to stockholders of record as of May 28, 2026. This represents the 220th consecutive quarterly dividend paid to stockholders in Chemed’s 55 years as a public company. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation...

Continue reading

MAISON POMMERY & ASSOCIES : Notice of meeting of the general meeting of holders of the bonds issued on 14 May 2019 and maturing on 19 June 2026 to amend their terms and conditions

Financial Press ReleaseNotice of meeting of the general meeting of holders of the bonds issued on 14 May 2019 and maturing on 19 June 2026 to amend their terms and conditions (ISIN: BE0002654359 – Common Code: 199972634)  Reims, 18 May 2026 Following its press release of 27 April 2026, in which it announced the postponement of the publication of its 2025 Universal Registration Document and of its Annual General Meeting of shareholders, Maison Pommery & Associés (the “Company”) is continuing discussions with its banking creditors in an orderly framework, with a view to providing the Company with the financial structure best suited to its needs and preserving the interests of all stakeholders. In this context, the Company is requesting a twelve-month extension of the maturity of the bonds bearing interest at a rate of 3.75 per cent...

Continue reading

Tim Lamb Group Completes Sale of Seven Firelands Automotive Group Dealerships in Northern Ohio

Dealerships sold to Feldman, Baumann, and Diehl Automotive Groups Columbus, OH, May 18, 2026 (GLOBE NEWSWIRE) — Tim Lamb Group has announced the completion of the sale of all seven Northern Ohio dealerships, formerly owned by Patrick O’Brien of Firelands Automotive Group, through a series of transactions finalized throughout April and May of 2026. The transactions were all facilitated by Tim Lamb, President and Director of the Northeast Region for the Tim Lamb Group. The Tim Lamb Group is widely recognized as one of North America’s leading automotive dealership sales and acquisitions firms, advising dealers nationwide, and in Canada, on strategic buy-sell transactions. Over the years, Tim Lamb has facilitated 15 individual dealership transactions for Firelands Automotive Group and the O’Brien family, including...

Continue reading

Olive Tree People Inc. Subsidiary Announces Launch of Hydroxytyrosol-Based Waterless Pet Brand ‘Is That Matty?’

Oliveda International, Inc. subsidiary Olive Tree People Inc. has developed a globally-unique, hydroxytyrosol-based “waterless” pet brand to serve a rapidly growing market SANTA MONICA, CA, May 18, 2026 (GLOBE NEWSWIRE) — Oliveda International, Inc. (OTCID: OLVI) today announced that its Olive Tree People subsidiary, the world leader in waterless beauty, is launching a globally unique, hydroxytyrosol-based “waterless” pet brand: “Is That Matty?” In 2019, Matty, an approximately 82-kilogram (180-pound) Spanish Mastiff, arrived in Venice Beach alongside Olive Tree People founder Thomas Lommel. Due to his immense size as well as his extraordinary friendliness and gentleness – particularly toward smaller dogs and other animals such as parrots, ducks, cats, raccoons, and mice – Matty quickly became a living legend...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.